Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Price:
39.76
USD
-0.13%
Market Cap:
$6.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
Resorttrust Inc
TSE:4681
|
JP |
|
C
|
Credit Suisse Group AG
XHAM:CSX
|
CH |
|
H
|
HIVE Blockchain Technologies Ltd
NASDAQ:HIVE
|
CA |
|
Paragon REIT
F:50E
|
SG |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
|
B
|
BPH Energy Ltd
ASX:BPH
|
AU |
|
O
|
Open Text Corp
SWB:OTX
|
CA |
|
I
|
Itmax System Bhd
KLSE:ITMAX
|
MY |
|
Vertex Inc
NASDAQ:VERX
|
US |
|
Compagnie De l'odet SE
PAR:ODET
|
FR |
|
F
|
First Tractor Co Ltd
OTC:FIRRY
|
CN |
|
Z
|
Zen Corporation Group PCL
SET:ZEN
|
TH |
|
G
|
Guangdong Investment Ltd
F:GUG
|
HK |
Wall St Price Targets
CNTA Price Targets Summary
Centessa Pharmaceuticals PLC
Centessa Pharmaceuticals PLC
Wall Street analysts forecast CNTA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CNTA is 44.88 USD with a low forecast of 38.38 USD and a high forecast of 65.1 USD.
Lowest Forecast
Price Target
38.38
USD
3% Downside
Average Forecast
Price Target
44.88
USD
13% Upside
Highest Forecast
Price Target
65.1
USD
64% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CNTA's stock price target?
Price Target
44.88
USD
44.88
USD
According to Wall Street analysts, the average 1-year price target for CNTA is 44.88 USD with a low forecast of 38.38 USD and a high forecast of 65.1 USD.
What is the Revenue forecast for Centessa Pharmaceuticals PLC?
Projected CAGR
87%
87%
The compound annual growth rate for Revenue over the next 8 years is 87%.
